TELEFLEX INC TFX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
3.56
Altman Z″ — distress risk · safe
-6.7%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.0B | -$905.6M | $1.1B | $1.4M | $3.1B |
| 2024 | $1.7B | $69.7M | $1.0B | $211.4M | $4.3B |
| 2023 | $1.7B | $356.3M | $1.0B | $159.7M | $4.4B |
| 2022 | $2.8B | $363.1M | $1.5B | $263.6M | $4.0B |
| 2021 | $2.8B | $485.4M | $1.5B | $580.5M | $3.8B |
| 2020 | $2.5B | $335.3M | $1.3B | $346.4M | $3.3B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Weidman Jason R. | President and CEO | 2026-06-08 | Grant | 53,983 | — |
| RANDLE STUART A | director | 2026-06-08 | Grant | 995 | — |
| RANDLE STUART A | director | 2026-06-08 | Grant | 4,663 | — |
| RANDLE STUART A | director | 2026-06-07 | Tax withheld | 4,054 | $129.84 |
| TOKICH MICHAEL J | director | 2026-05-15 | Grant | 1,090 | — |
| Patil Neena M | director | 2026-05-15 | Grant | 1,090 | — |
| Duncan Candace H | director | 2026-05-15 | Grant | 1,090 | — |
| Ryu Jaewon | director | 2026-05-15 | Grant | 1,090 | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.56 (safe)
- Working capital / assets 0.169
- Retained earnings / assets 0.453
- EBIT / assets 0.017
- Equity / liabilities 0.817
Source: SEC EDGAR filings · CIK 0000096943 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.